TRANSDERM SCOP Rx
Generic Name and Formulations:
Scopolamine 1.5mg (delivers approximately 1mg over 3 days); transdermal patch.
Novartis Consumer Health
Indications for TRANSDERM SCOP:
Prevention of motion sickness and post-op nausea and vomiting.
Apply to dry skin behind ear; do not cut patch. Motion sickness: 1 patch at least 4 hours before travel; remove after 72 hours. Post-op: 1 patch evening before surgery; for cesarean section: 1 patch 1 hour before surgery. Remove 24 hours after surgery.
Narrow angle glaucoma. Allergy to belladonna alkaloids.
Wash hands and skin after use; avoid eyes. GI or urinary tract obstruction. Hepatic, renal, or metabolic dysfunction. Seizure. Psychosis. Elderly. Pregnancy (Cat.C). Nursing mothers.
Alcohol, other CNS depressants potentiate CNS depression. Additive anticholinergic effects with other anticholinergics, antihistamines (e.g., meclizine), antidepressants. May affect absorption of other drugs.
Dry mouth, drowsiness, blurred vision, disorientation, confusion, difficult urination; withdrawal symptoms may occur if used for >3 days.
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder